Ovarian cancer screening

Clinical Obstetrics and Gynecology

Volumn 55, Issue 1, 2012, Pages 43-51

  Van Nagell, John R ^a   Pavlik, Edward John ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

ovarian cancer detection; ovarian screening trials; serum Ca 125; transvaginal sonography

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; OVARY CANCER; POSTMENOPAUSE; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

ALGORITHMS; CA-125 ANTIGEN; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS; OVARY; RESEARCH DESIGN;

EID: 84857572914     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182460c0d     Document Type: Article

References (22)

1. Siegel R, Ward E, Branty MD. Cancer statistics 2011.CACancer J Clin. 2011;61: 212-236.
2. Ueland FR, DePriest P, DeSimone C, et al. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol. 2005;99:400-403. (Pubitemid 41502851)
3. Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011; 61:183-203.
4. Havrilesky LJ, Sanders GD, Kulasingam S, et al. Development of an ovarian cancer screening decision model that incorporates disease heterogeneity. Cancer. 2011;117:545-553.
5. Yancik R. Ovarian cancer age contrasts in incidence, histology disease stage at diagnosis, mortality. Cancer. 1993;71: 517-523. (Pubitemid 23021245)
6. Lancaster JM, Powell CB, Kauff ND, et al. Statement in risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007;107: 159-162.
7. Crum CR, Drapkin R, Miron A, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3-9. (Pubitemid 46095865)
8. Kurman RT, Shih I. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433-443.
9. Finch A, Shaw P, Rosen B. Clinical and pathologic findings: Salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58-64. (Pubitemid 41815050)
10. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985-3990. (Pubitemid 47477278)
11. Yin BW, Dnistrian A, Lloy KO. Ovarian cancer antigen Ca-125 in encoded by the MUC 16 mucin gene. Int J Cancer. 2002;98:737-740. (Pubitemid 34225625)
12. Bast RC, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331-1337. (Pubitemid 12235035)
13. Higgins RV, van Nagell JR, Donaldson ES, et al. Transvaginal sonography as a screening method for ovarian cancer. Gynecol Oncol. 1989;34:402-406.
14. Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol. 2000;77:410-422.
15. Modesitt SC, Pavlik EJ, Ueland FR, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 cms in diameter. Obstet Gynecol. 2003;102:594-599. (Pubitemid 37311227)
16. Saunders BA, Podzielinski I, Ware RA, et al.Risk ofmalignancy in sonographically confirmed septated cystic ovarian tumors. Gynecol Oncol. 2010;118:278-282.
17. Ueland FR, DePriest PD, Pavlik EJ, et al. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol. 2003; 91:46-50. (Pubitemid 37188592)
18. Buys S, PartridgeE,Black A, et al.Effect of screening on ovarian cancer mortality. The prostate, lung, colorectal, and ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305:2295-2303.
19. Kobayashi H, Yamada Y, Sado T, et al.A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18:414-420. (Pubitemid 351668303)
20. Menon U, Gentry-Maharaj A, Hallert R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian screening (UKCTOCS). The Lancet. 2009;10:327-340.
21. van Nagell JR, Miller RW, DeSimone CP, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. (In press).
22. Partridge E, Kreimer AR, Greenlee RT, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113:775-782.